PUBCHEM ID | 71751880 |
Molecular Weight (g/mol) | 116.111 |
Molecular Formula | C4H4N2O2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 0 |
IUPAC Name | 2,3,5,6-tetradeuterio-4-oxidopyrazin-1-ium 1-oxide |
Canonical SMILES | O=[n+]1ccn([O-])cc1 |
PUBCHEM IUPAC INCHIKEY | SXTKIFFXFIDYJF-RHQRLBAQSA-N |
Solubility Level | 5 |
Vapour Pressure | -0.013 |
XLOGP3 AA | -1.6 |
CACTVS TPSA | 46.4 |
BBB Level | 4 |
Absorption Level | 3 |
EXT PPB#Prediction | 0 |
AlogP98 | -2.806 |
EXT CYP2D6#Prediction | 0 |
Mouse Female FDA | Multi-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Multi-Carcinogen |
Rat Male FDA | Multi-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | Toxic |
Rat Oral LD50 | 0.666422 g/kg_body_weight |
Ocular Irritancy | Moderate |
Hepatotoxic#Prediction | 1 |
Effected Human Genes |
Aerobic Biodegradability Prediction | Non-Degradable |
Physical hazards | not classified |
Health hazards | Mild |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | ||||||
2 | ||||||
3 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | Pyrazine, 1,4-dioxide |
Serial No. | Plant Name | Variety Name | Essential Oil | Compound Percentage |
---|---|---|---|---|
1 | Mulethi | Mishri | Glucyrrhiza glabra mulethi essential oil |